Aricept

   
Google
 
Web NewDrugInformation.com

Aricept


Drug - Aricept
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Donepezil Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 5MG
The potency of the active ingredient(s), Donepezil Hydrochloride. May repeat for multiple part products.

Applicant - EISAI MEDCL RES
The firm name holding legal responsibility for Aricept. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020690
The FDA assigned number to Aricept. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Aricept. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Nov 25, 1996
The date Aricept was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Aricept. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Aricept is in. Format is RX, OTC, DISCN.

Applicant Full Name - Eisai Medical Research Inc
The full name of the firm holding legal responsibility for the new application of Aricept.

Aricept